This week, Peter Simons covers the first peer-reviewed scientific article with specific guidance for discontinuing antipsychotic drugs, a study that found transcranial magnetic stimulation no better than sham treatment for bipolar disorder, and an FDA drug safety communication about the risk of heart arrhythmias with anticonvulsant drug lamotrigine (Lamictal).

• Major Publication on Tapering Antipsychotics Released
• Transcranial Magnetic Stimulation (TMS) Ineffective for People with Bipolar Disorder
• FDA Drug Safety Communication for lamotrigine

Visit madinamerica.com for more news, articles and research updates.